Media formats available:
Recommended
- Asian Cardio Diabetes Forum 2019ACDF Brief comments: What has changed significantly in evaluating and considering CV risk in managing patients with diabetes?1
Prof John E Deanfield
- Asian Cardio Diabetes Forum 2019ACDF Brief comments: The evolving role of SGLT2 inhibitors
Prof. Mark Cooper, MD
- Asian Cardio Diabetes Forum 2019Lecture: Heart Failure: The next frontier for SGLT2 inhibitors?
Prof. Nikolaus Marx, MD
- Asian Cardio Diabetes Forum 2019Lecture: Cardiovascular outcomes that will change diabetes practice: What are the key findings from recent trials
Prof. Mark Cooper, MD